USA: The investigational siRNA therapy cemdisiran met both its primary and a key secondary endpoint in the phase III NIMBLE ...
Argenx Brings Neuromuscular Leadership To AAN 2026 With New Data Supporting Broader VYVGART Use Across MG And CIDP. <li /> ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular ...
Caitlin Havener on MSN
Why is everyone suddenly obsessed with turmeric? Here's what it actually does for your body
There is something quietly fascinating happening in kitchens everywhere right now. Golden lattes are showing up on Instagram ...
Kyverna is hoping to nab FDA approval for the first treatment for SPS and the first CAR T-cell therapy for an autoimmune ...
Top 100 Companies Leading in Wellbeing 2026｜Business & Finance in partnership with Ibec – Part 1
Employing in the region of 500 people, ArraTipp is an Agri dairy-based organisation formed in March 2025, from the merger of ...
The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
Swedish and Italian scientists have found that anemia in people over the age of 60 is associated with a 66% increased risk of ...
Using single-nucleus RNA sequencing, the authors map transcriptional changes in the rat ventral tegmental area following chronic inflammatory pain and acute morphine exposure. Notably, their ...
Accurate measurement of HMGB-1, neopterin and sIL-2R supports reliable assessment of immune activation across clinical and ...
Objective Cardiovascular diseases are a leading cause of morbidity and mortality in SLE. In this target population, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results